The Value Signal — July 08, 2026

606 articles scanned · 12 high-signal

Signal Map

Executive Summary

Medicare Advantage is entering a litigation-and-evidence cycle: plans are defending coding integrity, contesting quality penalties, and repositioning VBC economics as CMS pushes digital and specialty-care models into harder-margin territory.

Risk, Stars, and MA economics are the live-fire zone. An external review found nearly 97% of diagnoses from UnitedHealth’s HouseCalls senior home visits were supported by medical records, Healthcare Dive reports, while Elevance is suing CMS over Star Ratings and seeking the same recalculation applied to Clover, MedCity News reports. The policy backdrop remains contested: Medicare Advantage companies are banking billions in bonuses, Cepr reports, while MedPAC found MA enrollment growth is not broadly damaging hospital or post-acute finances, according to HFMA.

VBC operating models are moving from aspiration to execution risk. CMS’ ACCESS model offers digital health companies annual Medicare payments that may be roughly equivalent to only a few commercial-insurer patient visits, Endpoints reports, underscoring the margin discipline required in chronic-care experiments. AI adoption in VBC is now universal but only 35% of organizations have documented processes to detect incorrect AI outputs and enforce accountability, Mathematica reports, while Highmark Blue Cross Blue Shield is collaborating on value-based cancer care, Bizjournals reports.